MyFinsight
Home
Blog
About
Contact
Download
Download image
Increase (decrease) in
cash and cash...
-$7,779,796
Decrease in amounts
receivable and prepaid...
$887,860
Increase in accrued
expenses and other...
$494,573
Share-based compensation
$294,686
Change in fair value of
the warrant...
$69,201
Equity losses
-$44,830
Depreciation
$22,839
Amortization
$3,818
Total cash flow from
operating activities
-$7,704,796
Total cash flow from
investing activities
-$75,000
Canceled cashflow
$1,817,807
Net loss for the
period
-$8,278,328
Equity investment in bc
therapeutics
$75,000
Decrease in accounts
payable
-$1,154,788
Financial expenses, net
$89,487
Back
Back
Cash Flow
source: myfinsight.com
BriaCell Therapeutics Corp. (BCTXZ)
BriaCell Therapeutics Corp. (BCTXZ)